Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Century Casinos | CNTY | 26. nov 2024 | 4.66 | +4.72 |
Century Communities | CCS | 26. nov 2024 | 91.11 | -3.68 |
Century Therapeutics | IPSC | 26. nov 2024 | 1.35 | +3.85 |
Cepton | CPTN | 26. nov 2024 | 3.13 | +0.32 |
Ceragon Networks | CRNT | 26. nov 2024 | 4.12 | +1.48 |
Cerence | CRNC | 26. nov 2024 | 6.47 | -8.36 |
CeriBell | CBLL | 26. nov 2024 | 27.68 | 0.00 |
CERo Therapeutics | CERO | 26. nov 2024 | 0.15 | -15.27 |
Certara | CERT | 26. nov 2024 | 10.93 | -1.09 |
Cerus | CERS | 26. nov 2024 | 1.76 | -3.30 |
CervoMed | CRVO | 26. nov 2024 | 7.98 | -8.90 |
CEVA | CEVA | 26. nov 2024 | 29.47 | -2.64 |
CF Acquisition VII A | CFFS | 26. nov 2024 | 11.21 | +0.09 |
CF Bankshares | CFBK | 26. nov 2024 | 27.80 | -0.71 |
CF Industries | CF | 26. nov 2024 | 88.14 | +0.86 |
CFSB Bancorp | CFSB | 26. nov 2024 | 6.70 | +0.90 |
CG Oncology | CGON | 26. nov 2024 | 33.90 | -0.15 |
CGI | GIB | 26. nov 2024 | 111.72 | -0.78 |
Chain Bridge Bancorp | CBNA | 26. nov 2024 | 24.19 | 0.00 |
Chain Bridge I SPAC A | CBRG | 26. nov 2024 | 11.49 | 0.00 |
Chain Bridge I Units | CBRGU | 26. nov 2024 | 11.26 | 0.00 |
Champion Homes | SKY | 26. nov 2024 | 103.45 | -0.77 |
Champions Oncology | CSBR | 26. nov 2024 | 4.33 | +3.59 |
ChampionX | CHX | 26. nov 2024 | 30.54 | -1.23 |
Channel Therapeutics | CHRO | 26. nov 2024 | 0.60 | -0.80 |
Chanson International | CHSN | 26. nov 2024 | 7.11 | -2.20 |
ChargePoint | CHPT | 26. nov 2024 | 1.15 | -8.00 |
Charles & Colvard | CTHR | 26. nov 2024 | 1.29 | +0.39 |
Charles River Laboratories International | CRL | 26. nov 2024 | 197.75 | -1.76 |
Charles Schwab | SCHW | 26. nov 2024 | 82.25 | +0.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.